4 articles
BASF completed the sale of its optical brightening agent business to ICIG's Catexel at the end of February. Around 80 employees were transferred to Catexel as part of the divestment transaction.
ICIG has agreed to acquire Venator's bankrupt Duisburg facility, which produces functional additives and nano-products for coatings and cosmetics. The deal preserves all 350 employees and supports ICI
ICIG acquires Venator's Duisburg facility producing functional additives and nano-fine products for coatings and cosmetics, while the Krefeld site remains in limbo.
BASF will sell its optical brightening agent business to ICIG’s Catexel, with the transaction closing in Q1 2026. This divestment impacts BASF's care chemicals portfolio.
ChemBrief